BNR
Burning Rock Biotech Ltd
NASDAQ: BNR · HEALTHCARE · DIAGNOSTICS & RESEARCH
$17.00
+4.68% today
Updated 2026-04-30
Market cap
$222.76M
P/E ratio
—
P/S ratio
0.41x
EPS (TTM)
$-0.75
Dividend yield
—
52W range
$2 – $42
Volume
0.0M
Burning Rock Biotech Ltd (BNR) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
0 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-1.2%
Most recent quarter
EPS YoY growth
+97.4%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.6%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.1%
2025-11-20
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.21 | — | $16.00 | $16.30 | +1.9% |
| 2025-11-20 | $-1.56 | — | $16.03 | $14.25 | -11.1% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | $-0.21 | — | $124.57M | -6.4% |
| 2025-09-30 | — | $-1.56 | — | $131.62M | +2.3% |
| 2025-06-30 | — | $-0.90 | — | $148.55M | +9.6% |
| 2025-03-31 | — | $-1.25 | — | $133.08M | +5.9% |
| 2024-12-31 | $-1.02 | $-7.87 | -671.6% | $126.02M | +4.1% |
| 2024-09-30 | — | $-0.48 | — | $128.64M | +0.8% |
| 2024-06-30 | $-1.08 | $-1.45 | -34.6% | $135.53M | -7.3% |
| 2024-03-31 | $-1.10 | $-1.65 | -49.9% | $125.62M | — |
| 2023-12-31 | $-3.24 | $-3.07 | +5.2% | $121.08M | — |
| 2023-09-30 | $-1.32 | $-1.71 | -29.5% | $127.57M | — |
| 2023-06-30 | $-1.86 | $-1.28 | +31.2% | $146.27M | — |
| 2023-03-31 | $-2.45 | $-1.81 | +26.1% | — | — |
Frequently asked questions
Has Burning Rock Biotech Ltd beaten earnings estimates?
Burning Rock Biotech Ltd has beaten Wall Street EPS estimates in 0 of its last 8 quarterly reports.
How does BNR stock react to earnings?
BNR stock has moved an average of -4.6% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Burning Rock Biotech Ltd's revenue growth rate?
Burning Rock Biotech Ltd reported year-over-year revenue growth of -1.2% in its most recent quarter, with EPS growing +97.4% year-over-year.